Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Andrea Carlini
Observed name:
A. Carlini
Institutions:
IRCCS Azienda Ospedliero-Universitaria di Bologna Policlinico di Sant'Orsola,
Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori,
University of Bologna
Observed institutions:
IRCCS Azienda Ospedliero-Universitaria di Bologna Policlinico di Sant'Orsola,
Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori,
University of Bologna
ORCID:
0009-0006-4575-8300
Observed ORCID:
0009-0006-4575-8300
OpenAlex ID:
A5030690954
The Multifaceted Role of Growth Differentiation Factor 15 (GDF15): A Narrative Review from Cancer Cachexia to Target Therapy
2025
·
Daria Maria Filippini
, Donatella Romaniello
, et al.
·
Biomedicines
·
21
PDF
Beyond EGFR inhibition in head and neck squamous cell carcinoma: Overcoming resistance mechanisms and novel therapeutic frontiers
2026
·
Francesca Carosi
, Daria Maria Filippini
, et al.
·
Critical Reviews in Oncology/Hematology
·
9
Efficacy and Safety of TROP-2-Targeting Antibody–Drug Conjugate Treatment in Previously Treated Patients with Advanced Non-Small Cell Lung Cancer: A Systematic Review and Pooled Analysis of Reconstructed Patient Data
2025
·
Sara Stumpo
, Andrea Carlini
, et al.
·
Cancers
·
9
PDF
Transdermal Fentanyl in Patients with Cachexia—A Scoping Review
2024
·
Andrea Carlini
, Emanuela Scarpi
, et al.
·
Cancers
·
7
PDF
The role of systemic therapy in patients with recurrent or metastatic head and neck squamous cell carcinoma progressed to immunotherapy: A systematic review and meta analysis
2025
·
Alicia Tosoni
, Vincenzo Di Nunno
, et al.
·
Oral Oncology
·
3
Real-world survival benefit of glucagon-like peptide-1 receptor agonists (GLP-1 Ras) concomitant with cyclin-dependent kinase 4/6 inhibitors (CDK4/6i) and endocrine therapy in hormone receptor-positive (HR+)/HER2− metastatic breast cancer: A large propensity-matched analysis.
2026
·
Michela Palleschi
, Caterina Gianni
, et al.
·
Journal of Clinical Oncology
·
2
Artificial intelligence for predicting pathological complete response to neoadjuvant therapy in triple-negative breast cancer: A systematic review and meta-analysis
2026
·
Andrea Carlini
, Flavia Foca
, et al.
·
The Breast
·
1
Glucagon-like Peptide-1 Receptor Agonists (glp-1ras) and the Risk of Gynecological Malignancies in Diabetic Patients
2026
·
Alberto Farolfi
, Chiara Casadei
, et al.
·
International Journal of Gynecological Cancer
Advancing therapies for HER2-positive metastatic breast cancer: Navigating a wealth of treatment options
2026
·
Michela Palleschi
, Alessandro Viansone
, et al.
·
Cancer Treatment Reviews
PDF
How can we monitor disease in real time?
2026
·
Andrea Carlini
·
Futurum Careers
PDF
Impact of genetic polymorphisms on the response to transdermal fentanyl in cancer patients—a single-center, prospective, biological study
2026
·
Lucia Angelini
, Irene Azzali
, et al.
·
Frontiers in Pain Research
PDF
Refining Prognostic Stratification in Head and Neck Paragangliomas: Insights from a SEER-Based Population Study
2026
·
Andrea Carlini
, Mirea Berti
, et al.
·
Annals of Otology Rhinology & Laryngology
Identification of palliative care needs and prognostic factors of survival for tailoring appropriate interventions in advanced oncological, renal, and pulmonary diseases: results from a prospective observational study in an Italian population
2026
·
Emanuela Scarpi
, Vanessa Valenti
, et al.
·
BMC Palliative Care
Identification of palliative care needs and prognostic factors of survival for tailoring appropriate interventions in advanced oncological, renal, and pulmonary diseases: results from a prospective observational study in an Italian population
2026
·
Emanuela Scarpi
, Vanessa Valenti
, et al.
·
Figshare
Hospice admission of cancer patients receiving disease-modifying therapies near the end of life: implications for eligibility criteria
2026
·
Carla Bettini
, Andrea Carlini
, et al.
·
Tumori Journal
Pembrolizumab–lenvatinib beyond immunotherapy progression in endometrial cancer: A real-world analysis.
2026
·
Alberto Farolfi
, Chiara Casadei
, et al.
·
Journal of Clinical Oncology
Abstract PS2-04-03: Herpes zoster vaccination and risk of breast cancer in women undergoing mammographic screening: a trinetx real-world analysis
2026
·
O. Serra
, A. Farolfi
, et al.
·
Clinical Cancer Research
Abstract PS2-04-06: Real-world outcomes of trastuzumab deruxtecan with or without endocrine therapy in her2-low, hormone receptor-positive metastatic breast cancer: a propensity-matched analysis
2026
·
M. Palleschi
, A. Farolfi
, et al.
·
Clinical Cancer Research
Abstract PS3-01-01: Impact of medically assisted procreation and pregnancy on breast and gynecologic cancer risk in women under 45: a real-world, propensity-matched analysis using the trinetx network
2026
·
G. Miserocchi
, A. Farolfi
, et al.
·
Clinical Cancer Research
XXIII Rapporto di monitoraggio del sistema di Istruzione e Formazione Professionale e dei percorsi in Duale nella IeFP a.f. 2023-2024
2026
·
Emmanuele Crispolti
, Andrea Carlini
Role of Hpv Vaccination After Carcinoma in Situ of Cervix Uteri (cin) in Real-world Patients
2025
·
Alberto Farolfi
, Elisabetta Petracci
, et al.
·
International Journal of Gynecological Cancer
WITHDRAWN: 1455eP the role of systemic therapy in patients with recurrent or metastatic head and neck squamous cell carcinoma progressed to immunotherapy: A systematic review and meta analysis
2025
·
V. Di Nunno
, A. Carlini
, et al.
·
Annals of Oncology
Show more works
View as search
Works count:
23
Citation count:
52
H-index:
4
I10-index:
1
Year
Topic
Type